共 33 条
- [2] BERTHOU F, 1991, DRUG METAB DISPOS, V19, P561
- [3] COMPARATIVE PHARMACOKINETICS OF CAFFEINE IN YOUNG AND ELDERLY MEN [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1983, 11 (02): : 109 - 126
- [4] FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) : 1211 - 1214
- [5] HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) : 7696 - 7700
- [6] DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J]. PHARMACOGENETICS, 1992, 2 (03): : 116 - 127
- [7] CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237
- [10] CHARNEY DS, 1985, ARCH GEN PSYCHIAT, V42, P233